S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway

Greenbrook TMS (GBNH) Competitors

$0.05
0.00 (0.00%)
(As of 02/26/2024)

GBNH vs. MGRX, OTRK, BRTX, ALLR, NUWE, SPRC, ATXI, NEPT, SIEN, and WINT

Should you be buying Greenbrook TMS stock or one of its competitors? The main competitors of Greenbrook TMS include Mangoceuticals (MGRX), Ontrak (OTRK), BioRestorative Therapies (BRTX), Allarity Therapeutics (ALLR), Nuwellis (NUWE), SciSparc (SPRC), Avenue Therapeutics (ATXI), Neptune Wellness Solutions (NEPT), Sientra (SIEN), and Windtree Therapeutics (WINT). These companies are all part of the "medical" sector.

Greenbrook TMS vs.

Greenbrook TMS (NASDAQ:GBNH) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Greenbrook TMS received 19 more outperform votes than Mangoceuticals when rated by MarketBeat users.

CompanyUnderperformOutperform
Greenbrook TMSOutperform Votes
19
50.00%
Underperform Votes
19
50.00%
MangoceuticalsN/AN/A

Greenbrook TMS currently has a consensus price target of $3.00, indicating a potential upside of 6,150.00%. Given Greenbrook TMS's higher probable upside, research analysts clearly believe Greenbrook TMS is more favorable than Mangoceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenbrook TMS
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Mangoceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Mangoceuticals has lower revenue, but higher earnings than Greenbrook TMS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenbrook TMS$69.10M0.03-$61.73M-$2.12-0.02
Mangoceuticals$10K398.22-$2MN/AN/A

Greenbrook TMS has a net margin of -83.19% compared to Mangoceuticals' net margin of -1,472.66%. Greenbrook TMS's return on equity of 0.00% beat Mangoceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Greenbrook TMS-83.19% N/A -66.59%
Mangoceuticals -1,472.66%-332.08%-291.61%

In the previous week, Mangoceuticals had 3 more articles in the media than Greenbrook TMS. MarketBeat recorded 4 mentions for Mangoceuticals and 1 mentions for Greenbrook TMS. Greenbrook TMS's average media sentiment score of 1.89 beat Mangoceuticals' score of 0.22 indicating that Greenbrook TMS is being referred to more favorably in the media.

Company Overall Sentiment
Greenbrook TMS Very Positive
Mangoceuticals Neutral

64.3% of Greenbrook TMS shares are held by institutional investors. Comparatively, 0.0% of Mangoceuticals shares are held by institutional investors. 21.7% of Greenbrook TMS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Greenbrook TMS beats Mangoceuticals on 10 of the 13 factors compared between the two stocks.


Get Greenbrook TMS News Delivered to You Automatically

Sign up to receive the latest news and ratings for GBNH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GBNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GBNH vs. The Competition

MetricGreenbrook TMShealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$1.96M$2.07B$5.21B$7.62B
Dividend YieldN/A2.16%2.82%3.87%
P/E Ratio-0.0217.62257.3718.81
Price / Sales0.0336.013,092.04110.79
Price / CashN/A15.4799.8655.35
Price / Book-0.032.864.534.54
Net Income-$61.73M$82.58M$114.95M$211.55M
7 Day PerformanceN/A-0.13%5.72%3.36%
1 Month PerformanceN/A-2.57%12.81%6.70%
1 Year PerformanceN/A-13.61%12.92%7.44%

Greenbrook TMS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGRX
Mangoceuticals
0 of 5 stars
$0.22
+10.2%
N/AN/A$3.76M$10,000.000.002Short Interest ↑
Gap Down
OTRK
Ontrak
2.4879 of 5 stars
$0.19
-5.1%
$4.00
+2,062.2%
-95.5%$5.10M$11.71M-0.02118Short Interest ↑
News Coverage
Gap Up
High Trading Volume
BRTX
BioRestorative Therapies
1.7196 of 5 stars
$1.28
-4.5%
N/AN/A$6.03M$130,200.000.0010Upcoming Earnings
Short Interest ↑
ALLR
Allarity Therapeutics
0 of 5 stars
$0.40
+5.3%
N/A-99.8%$1.91MN/A0.0014Upcoming Earnings
NUWE
Nuwellis
0.3535 of 5 stars
$0.62
-11.4%
N/A-92.7%$2.02M$8.54M-0.0470Upcoming Earnings
Short Interest ↑
Gap Up
SPRC
SciSparc
0 of 5 stars
$3.91
+4.5%
N/A-79.3%$2.03M$1.35M0.003Short Interest ↓
News Coverage
Gap Up
ATXI
Avenue Therapeutics
4.0688 of 5 stars
$0.15
+6.9%
$32.00
+20,612.0%
-86.2%$2.05MN/A-0.262Short Interest ↓
Gap Down
NEPT
Neptune Wellness Solutions
0.2442 of 5 stars
$0.41
+10.9%
N/A-98.1%$1.84M$52.62M0.0058Analyst Report
Short Interest ↑
High Trading Volume
SIEN
Sientra
0.7033 of 5 stars
$0.17
-18.7%
$7.50
+4,210.3%
N/A$2.08M$90.55M-0.03304Analyst Report
Gap Down
WINT
Windtree Therapeutics
1.3284 of 5 stars
$0.36
+9.2%
N/A-93.6%$1.83MN/A-0.0220Short Interest ↓
News Coverage

Related Companies and Tools

This page (NASDAQ:GBNH) was last updated on 3/3/2024 by MarketBeat.com Staff